RECRUITING

Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer

Description

This study assesses breast cancer screening adherence for women at moderately increased risk for developing breast cancer based on gene mutation status or empiric risk model estimates. It also seeks to determine facilitators and barriers to screening.

Conditions

Breast Carcinoma
Talk to us

Related Conditions:

Breast Carcinoma

Study Overview

On this page

Study Details

Study overview

This study assesses breast cancer screening adherence for women at moderately increased risk for developing breast cancer based on gene mutation status or empiric risk model estimates. It also seeks to determine facilitators and barriers to screening.

Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer

Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer

Condition
Breast Carcinoma
Intervention / Treatment

-

Contacts and Locations

Los Angeles

Los Angeles General Medical Center, Los Angeles, California, United States, 90033

Los Angeles

USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States, 90033

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * \* \>= 30 years
  • * =\< 75 years
  • * Women with either:
  • * Genetic test results showing moderately increased breast cancer risk due to a pathogenic/likely pathogenic variant in ATM, CHEK2, BARD1, RAD51C, or RAD51D (Mutation carrier group) OR
  • * Calculated lifetime breast cancer risk estimates between 20% and 40% according to the Tyrer-Cuzick V8.0B empiric risk model (Empiric risk group)
  • * Patients provided breast cancer risk assessments by genetic counselors at USC Norris or LA General Hospital beginning in 2021 and at least 12 months ago
  • * Women recommended to undergo annual breast MRI and/or annual mammogram beginning at the time of their genetic counseling risk assessment
  • * English or Spanish speaking patients
  • * \* History of breast cancer before genetic counseling at University of Southern California (USC)
  • * Any metastatic cancer diagnosis at time of genetic counseling risk assessment
  • * Deceased
  • * Patient underwent a risk reducing mastectomy before their genetic counseling risk assessment

Ages Eligible for Study

30 Years to 75 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Southern California,

Jacob Comeaux, PRINCIPAL_INVESTIGATOR, University of Southern California

Study Record Dates

2028-06-02